Changes in Study Status and Arms and Interventions With Illuminate-301 ... | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1450 of 1474  at  6/18/2019 12:37:13 PM  by

cert77


 In response to msg 1447 by  raferjack
view thread

Re: Changes in Study Status and Arms and Interventions With Illuminate-301 ...

All confusion cleared now..The Ph-3 trial design has been set for week 2,5,8,11 as it has been in prior studies including phase 1/2 from the start of the Ph-3 trial. As always, for some unknown reason there was error popped up in clinical trial website which company might have requested to get it fixed. So, this from day-1 the trial design is week 2,5,8,11


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 105
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...